Meeting the needs of millions still waiting for affordable treatment

Hepatitis C

Meeting the needs of millions still waiting for affordable treatment

We have developed a simple-to-use, affordable cure and tested new strategies to link patients to lifesaving treatment and care. We are also working to foster the political will needed for wide-scale roll-out of test-and-treat strategies together with allies in the Hepatitis C Partnership for Control and Treatment (Hepatitis C PACT).

Hepatitis C is caused by the blood-borne hepatitis C virus that can lead to chronic liver disease, cirrhosis, cancer, and, if not treated, death. Symptoms can take decades to develop and most people living with the disease do not know they are infected. As a result, hepatitis C is a silent epidemic.

Recent years have seen a revolution in medical innovation for hepatitis C, which can now be cured with just 8 to 24 weeks of safe, simple treatment. However, just 13% of people living with the disease worldwide have benefited. In many countries, high prices remain a major barrier for ‘test-and-treat’ strategies that have the potential to eliminate hepatitis C altogether.

0 million

people have hepatitis C

0 %

are unaware they are infected

0 %

have had access to treatment

people die every day

‘Hepatitis C is a “silent epidemic” because people are unaware of their infection and go untreated for years.’

Sasikala Siva, DNDi Clinical Project Manager in Kuala Lumpur, Malaysia

What we have achieved

We delivered a new treatment that is equal to the best hepatitis C drugs, at a fraction of the cost.

Loading…

Registration & access

Ravidasvir + sofosbuvir

An affordable cure to leave no one behind. We have developed a new simple-to-use, affordable treatment for hepatitis C to increase access and minimize financial burden on patients and health systems. Trial results in Malaysia showed 97% of people treated were cured.

What we are doing for people living with hepatitis C

We are now working to help foster an enabling environment for improved availability of hepatitis C diagnostics and treatments in low- and middle-income countries and supporting innovative ‘test-and-treat’ programmes in several countries.

Loading…

Hepatitis C PACT

This partnership is working to foster an enabling environment for HCV testing and treatment by rolling out all-oral cures, scaling up community-based testing to help find the missing millions of undiagnosed people, and addressing domestic financial challenges that may prevent the launch and scale-up of national programmes.

Registration & access

Hepatitis C Screening in Malaysia – #MYMissingMillions

Leading by example in access and innovation. A pioneer in efforts to tackle hepatitis C, the Malaysian government is joining with DNDi partner Foundation for Innovative New Diagnostics (FIND) to pilot the use of simple rapid diagnostic tests to link more people to lifesaving treatment and care.